lncRNA MEG3 can separate and bind SOX2 from the BMP4 promoter, then block the activation of SOX2 on the promoter, and reduce the inhibition of SOX2 on BMP4 transcription, to promote osteogenesis of MSCs in patients with MM [44]. Here, SOX2 is linked to Miyoshi myopathy.